[English] 日本語
Yorodumi- EMDB-61741: Structure of interleukin receptor common gamma chain (IL2Rgamma/C... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Structure of interleukin receptor common gamma chain (IL2Rgamma/CD132) in complex with 2D4 | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | IL2Rg / CD132 / IL-2 / 2D4 / MEMBRANE PROTEIN | |||||||||
| Function / homology | Function and homology informationmature B cell differentiation / interleukin-15 receptor activity / interleukin-2 binding / CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation / positive regulation of T cell differentiation in thymus / lymphocyte differentiation / Interleukin-9 signaling / Interleukin-21 signaling / interleukin-7-mediated signaling pathway / interleukin-9-mediated signaling pathway ...mature B cell differentiation / interleukin-15 receptor activity / interleukin-2 binding / CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation / positive regulation of T cell differentiation in thymus / lymphocyte differentiation / Interleukin-9 signaling / Interleukin-21 signaling / interleukin-7-mediated signaling pathway / interleukin-9-mediated signaling pathway / interleukin-4-mediated signaling pathway / positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation / interleukin-2-mediated signaling pathway / interleukin-15-mediated signaling pathway / cellular homeostasis / STAT3 nuclear events downstream of ALK signaling / Interleukin-15 signaling / cytokine receptor activity / Interleukin-2 signaling / positive regulation of B cell differentiation / positive regulation of immunoglobulin production / cytokine binding / Interleukin receptor SHC signaling / coreceptor activity / Interleukin-7 signaling / positive regulation of phagocytosis / cytokine-mediated signaling pathway / T cell differentiation in thymus / RAF/MAP kinase cascade / Interleukin-4 and Interleukin-13 signaling / gene expression / receptor complex / endosome / immune response / external side of plasma membrane / cell surface / signal transduction / nucleoplasm / membrane / plasma membrane / cytosol Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) / ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.7 Å | |||||||||
Authors | Lu QJ / Yin HQ | |||||||||
| Funding support | China, 2 items
| |||||||||
Citation | Journal: Signal Transduct Target Ther / Year: 2024Title: 2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus. Authors: Huiqi Yin / Liming Li / Xiwei Feng / Zijun Wang / Meiling Zheng / Junpeng Zhao / Xinyu Fan / Wei Wu / Lingyu Gao / Yijing Zhan / Ming Zhao / Qianjin Lu / ![]() Abstract: Current therapies for systemic lupus erythematosus that target a particular factor or cell type exhibit limited effectiveness. To address this limitation, our focus was on CD132, a subunit common to ...Current therapies for systemic lupus erythematosus that target a particular factor or cell type exhibit limited effectiveness. To address this limitation, our focus was on CD132, a subunit common to six inflammatory factor receptors implicated in SLE. Our study revealed heightened CD132 expression in SLE patients' lymphocytes, contributing to the production of pro-inflammatory cytokines and immunoglobulins. We developed a novel humanized anti-CD132 monoclonal antibody, named as 2D4. 2D4 efficiently blocked IL-21 and IL-15, with limited effectiveness against IL-2, thereby suppressing T and B cells without disrupting immune tolerance. In the mouse immunization model, 2D4 virtually inhibited T cell-dependent, antigen-specific B-cell response. In lupus murine models, 2D4 mitigated inflammation by suppressing multiple pro-inflammatory cytokines and anti-dsDNA antibody titers, also diminishing proteinuria and glomerulonephritis. Compared to Belimumab, 2D4 exhibited superior efficacy in ameliorating the inflammatory state and preserving renal function. Moreover, 2D4 exhibited the ability to inhibit the production of pro-inflammatory factors and autoantibodies in PBMCs from individuals with SLE, highlighting its therapeutic potential for SLE individuals. Potent, 2D4 has the potential to significantly improve clinical outcomes in SLE and other complex autoimmune disorders. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_61741.map.gz | 117.7 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-61741-v30.xml emd-61741.xml | 17.9 KB 17.9 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_61741_fsc.xml | 10.6 KB | Display | FSC data file |
| Images | emd_61741.png | 84.8 KB | ||
| Masks | emd_61741_msk_1.map | 125 MB | Mask map | |
| Filedesc metadata | emd-61741.cif.gz | 6.1 KB | ||
| Others | emd_61741_half_map_1.map.gz emd_61741_half_map_2.map.gz | 115.9 MB 115.9 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-61741 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-61741 | HTTPS FTP |
-Validation report
| Summary document | emd_61741_validation.pdf.gz | 1 MB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_61741_full_validation.pdf.gz | 1 MB | Display | |
| Data in XML | emd_61741_validation.xml.gz | 19.1 KB | Display | |
| Data in CIF | emd_61741_validation.cif.gz | 24.5 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-61741 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-61741 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9jqtMC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_61741.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.722 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Mask #1
| File | emd_61741_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_61741_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_61741_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Interleukin receptor common gamma chain (IL2Rgamma/CD132) in comp...
| Entire | Name: Interleukin receptor common gamma chain (IL2Rgamma/CD132) in complex with 2D4 |
|---|---|
| Components |
|
-Supramolecule #1: Interleukin receptor common gamma chain (IL2Rgamma/CD132) in comp...
| Supramolecule | Name: Interleukin receptor common gamma chain (IL2Rgamma/CD132) in complex with 2D4 type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Cytokine receptor common subunit gamma
| Macromolecule | Name: Cytokine receptor common subunit gamma / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 28.301557 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: LNTTILTPNG NEDTTADFFL TTMPTDSLSV STLPLPEVQC FVFNVEYMNC TWNSSSEPQP TNLTLHYWYK NSDNDKVQKC SHYLFSEEI TSGCQLQKKE IHLYQTFVVQ LQDPREPRRQ ATQMLKLQNL VIPWAPENLT LHKLSESQLE LNWNNRFLNH C LEHLVQYR ...String: LNTTILTPNG NEDTTADFFL TTMPTDSLSV STLPLPEVQC FVFNVEYMNC TWNSSSEPQP TNLTLHYWYK NSDNDKVQKC SHYLFSEEI TSGCQLQKKE IHLYQTFVVQ LQDPREPRRQ ATQMLKLQNL VIPWAPENLT LHKLSESQLE LNWNNRFLNH C LEHLVQYR TDWDHSWTEQ SVDYRHKFSL PSVDGQKRYT FRVRSRFNPL CGSAQHWSEW SHPIHWGSNT SKENPFLFAL EA UniProtKB: Cytokine receptor common subunit gamma |
-Macromolecule #2: 2D4-Heavy Chain
| Macromolecule | Name: 2D4-Heavy Chain / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.049832 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: QVQLVQSGAE VKKPGSSVKV SCKTSGFNIE DIYLHWVRQA PGQGLEWMGR IDPANGKSNY DPKFQGRVTI TADTSTSTAY MELSSLRSE DTAVYYCAAL RFFGLDYWGQ GTLVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN S GALTSGVH ...String: QVQLVQSGAE VKKPGSSVKV SCKTSGFNIE DIYLHWVRQA PGQGLEWMGR IDPANGKSNY DPKFQGRVTI TADTSTSTAY MELSSLRSE DTAVYYCAAL RFFGLDYWGQ GTLVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN S GALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTKTY TCNVDHKPSN TKVDKRV |
-Macromolecule #3: 2D4-Light Chain
| Macromolecule | Name: 2D4-Light Chain / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.347873 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: EIVLTQSPAT LSLSPGERAT LSCRATSSVS YMYWYQQKPG QAPELLIYRT SNLASGIPAR FSGSGSGTDY TLTISSLEPE DFAVYYCQQ WSSNPPTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ E SVTEQDSK ...String: EIVLTQSPAT LSLSPGERAT LSCRATSSVS YMYWYQQKPG QAPELLIYRT SNLASGIPAR FSGSGSGTDY TLTISSLEPE DFAVYYCQQ WSSNPPTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ E SVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC |
-Macromolecule #4: Anti-Fab nanobody
| Macromolecule | Name: Anti-Fab nanobody / type: protein_or_peptide / ID: 4 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 14.219525 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: GSQVQLQESG GGLVQPGGSL RLSCAASGRT ISRYAMSWFR QAPGKEREFV AVARRSGDGA FYADSVQGRF TVSRDDAKNT VYLQMNSLK PEDTAVYYCA IDSDTFYSGS YDYWGQGTQV TVSSHHHHHH |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 0.2 mg/mL |
|---|---|
| Buffer | pH: 7.5 |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Name: TFS Selectris / Energy filter - Slit width: 10 eV |
| Image recording | Film or detector model: TFS FALCON 4i (4k x 4k) / Digitization - Dimensions - Width: 4096 pixel / Digitization - Dimensions - Height: 4096 pixel / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 100.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
China, 2 items
Citation



Z (Sec.)
Y (Row.)
X (Col.)













































Processing
FIELD EMISSION GUN

